Introduction - Uppsala Monitoring Centre

Ernst E and Resch K.L. Concepts of true and perceived placebo effects. BMJ 1995; 311: 551–3.
Ersley A J, and Wintrobe MM. Detection and prevention of drug-induced blood dyscrasias. JAMA 1962; 181: 114, 37.
Esbach and Bérard. Ictère hémolytique mortel après traitement prolongé par l’atophan. Bull Soc Méd Hôpital Paris 1937; 21
Mai: 717.
Esunge PM. From blood pressure to hypertension: the history of research. J R Soc Med 1991; 84(10): 621.
Etkin NL. ‘Side effects’: cultural constructions and reinterpretations of western pharmaceuticals. Med Anthropol Q 1992; 6(2):
99–113.
Euripides. The Bacchae and other plays. Translated by Philip Velacott. Penguin Classics, 1972.
Evans GM and Gaisford WF. Treatment of pneumonia with 2-(p- aminobenzenesulphonamido) pyridine. Lancet July 2nd
1938; 14–19.
FPHRCP (Faculty of Public Health Royal College of Physicians). A chronology of state medicine, public health welfare and
related services in Britain 1066–1990. Compiled by MD Warren 2000.
Fabre, Traité des maladies vénériennes, 1765.
Fabry von Hilden W. Von der Fürtrefflichkeit und Nutz der Anatomie [On the excellence and use of anatomy], H.R.
Sauerländer & Co. Aarau, Leipzig. 1936.
Fanconi, Botsztejn and Schenker. Réaction d’hypersensibilité à la médication mercurielle dans l’enfance avec une
consideration particulière de la maladie du calomel. Clinique Infantile de Zurich. Helv Paed Acta 1947; Suppl.2.
Farber SM and Eagle HR. Streptomycin therapy of tuberculosis. Calif Med 1948; 69(1): 6–11.
Farrington RF, Hull-Smith H, Bunn PA, and McDermott W. Streptomycin toxicity- reactions to highly purified drug on longcontinued
administration to human subjects. JAMA 1947; 134: 679.
FDA Modernisation Act of 1997, section 503A (a) Proposed list of agents not to be compounded due to withdrawal for
safety/efficacy concerns. (http://www. ijpc.com/chart.html) accessed on 30th April 2002.
FDA. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. 21
CFR Part 216, 1999.
Featherstone WH. Convulsions following use of Astérol dihydrochloride. Report of a case. JAMA 1952; 150: 1006.
Feinman SE. Beneficial and Toxic Effects of Aspirin. Edited by S E Feinman. CRC Press. 1994.
Feldman WH and Hinshaw HC. Streptomycin: a valuable anti-tuberculosis agent. BMJ 1948 January 17th; 87–92.
Fernel J. De luis venereae curatione perfectissma liber. Antwerp, 1579.
Ferner R. The Dawn of Drug Safety Br J Clin Pharmacol 2011; 71(1): 141.
Feund* Deuts Med Irchnechr April 27th 1905.
Fiks AP. Self-experimenters: Sources for study. West Port: Praeger Publishers. 2003.
Finney DJ. The design and logic of a monitor of drug use. J Chron Dis 1965; 18: 77-98.
Flückner FA and Hanbury D. Pharmacographia; A history of the principal drugs of vegetable origins met with in Great Britain
and British India. Second ed. London, MacMillan. and Co, 1879, pp 567–571.
Foster RHK. Standardisation of safety margin. J Pharmacol Experimental Therap 1939; 65: 1–18.
Fouassier Eric. Le cadre général de la loi du 21 germinal An XI. March 2003.
Fowler EP and Seligman E. Otic complications of streptomycin therapy. JAMA 1947; 133(2): 87–91.
Fowler T. Medical reports of the effects of arsenic, in the cure of agues, remitting fevers, and periodic headaches. Together
with a letter from Dr Arnold of Leicester, and another from Dr Withering. London 1786, Eighteenth century collections Online,
Gale Group.
Fox TC. The complications of vaccination BMJ 1902; June 5 th p35-6.
Francis. The effects of mercury in its natural state and on its abuse in certain diseases. The Medical and Physical Journal
1815; 207.
Fraunfelder FT, Bagby GC, Kelly DJ, Abrams SM, Degnan TJ and Vinciguerra V. Fatal aplastic anaemia following topical
administration of ophthalmic chloramphenicol. Am J Ophthlmol 1982; 93: 356–60.
Freie HMP. Antipyretic analgesics. Meyler’s ‘Side Effects of Drugs’. 14th edition. Eds. Dukes MNG and Aronson JK. Levier,
2000.
Freind John. The history of physick; from the time of Galen, to the beginning of the sixteenth century. Chiefly with regard to
practice. In a discourse written to Doctor Mead. By J. Freind, M.D. Part I. Containing all the Greek writers. The second edition,
corrected London, 1725. Eighteenth Century Collections Online. Gale Group.
Fréjaville J-P, Bessel J, Leclerk J-P, Guillam L, Crabie P, Conso F, Gervais P and Gaultier M. Intoxication aiguë par les
dérivés arsenicaux; (à propos de 4 observations personelles); troubles de l’hémostase; étude ultramicroscopique du foie et du
rein. Ann Méd Interne 1972; 123(8–9): 713–722.
Frobenius WG. An account of a Spiritus Vini Aetherus. Philos Trans R Soc Lond 1730.
Fung M, Thornton A, Mybeck K, Hsiao-Hui J, Hornbuckle K and Muniz E. Evaluation of the characteristics of safety withdrawal